Participant Characteristics at Baseline
| Baseline Data | Intervention (n = 9) | Control (n = 9) | P Value |
|---|---|---|---|
| Age (years) | |||
| Mean | 56.2 | 60.4 | .45* |
| SD | 9.1 | 12.5 | |
| Duration of RLS (years) | |||
| Mean | 20.1 | 17.1 | .7* |
| SD | 18.1 | 11.9 | |
| HAP (MAS) | |||
| Mean | 77.1 | 78.6 | .78* |
| SD | 7.0 | 11.2 | |
| HAP (AAS) | |||
| Mean | 72.2 | 72.3 | .99* |
| SD | 9.3 | 15.2 | |
| Gender | |||
| Male | .02 | ||
| n | 1 | 6 | |
| % | (11%) | (67%) | |
| Female | |||
| n | 8 | 3 | |
| % | (89%) | (33%) | |
| Family history | |||
| RLS | .26 | ||
| n | 3 | 1 | |
| % | (33%) | (11%) | |
| Parkinson's disease | .53 | ||
| n | 2 | 1 | |
| % | (22%) | (11%) | |
| Medications | |||
| Yes | .11 | ||
| n | 4 | 1 | |
| % | (44%) | (11%) | |
| No | |||
| n | 5 | 8 | |
| % | (56%) | (89%) | |
| Other therapies | |||
| Yes | .63 | ||
| n | 4 | 3 | |
| % | (44%) | (33%) | |
| No | |||
| n | 5 | 6 | |
| % | (56%) | (67%) | |
| Comorbidities | P1: Sciatica, OA ankle, ‘Cold feet’ P2: Anxiety, Depression, Shoulder injury P3: OA knees | P10: Depression, Fibromyalgia, Reflux P11: HT High cholesterol, High iron levels, Joint pain, Enlarged prostate P12: Asthma, Fibromyalgia, RSI arms/wrists, Arthritis back, neck, foot, Osteopenia, Coeliac disease |
AAS, adjusted activity score; HAP, human activity profile; HT, hypertension; MAS, maximum activity score; OA, osteoarthritis; P1, P2, P3, etc., participant 1, 2, 3, etc.; RLS, restless legs syndrome; RSI, repetitive strain injury; SD, standard deviation.
↵* t tests, other p values derived from χ2 tests.